About
Natural and synthetic bacteriophage-based therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirus TechnologySan Diego & Southern California
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
533
By Phase
PHASE2: 8PHASE1/PHASE2: 2PHASE1: 1
By Status
COMPLETED: 11NO_LONGER_AVAILABLE: 2
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05616221Lead Sponsor
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
PHASE2Completed
48 participants
Started: Jan 10, 2023 · Completed: Aug 8, 2024
NCT05184764Lead Sponsor
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
PHASE1/PHASE2Completed
50 participants
Started: Apr 26, 2022 · Completed: Jan 14, 2025
NCT04596319Lead Sponsor
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
PHASE1/PHASE2Completed
29 participants
Started: Dec 22, 2020 · Completed: Dec 14, 2022
NCT03196219Lead Sponsor
A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
PHASE2Completed
20 participants
Started: Jul 7, 2017 · Completed: Jan 10, 2018
NCT03052842Lead Sponsor
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
PHASE2Completed
30 participants
Started: Feb 9, 2017 · Completed: Apr 5, 2017
Locations (1)
Headquarters
Los Angeles, CA, United States
Map
Loading map...